SCHEMBL7673571

SCHEMBL7673571

O=S(=O)(O)C1CNc2ccccc21

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KCNH2 Q12809 1/20 0.33
▸ ALDH1A1 P00352 1/20 0.33
▸ CCKBR P32239 2/20 0.32
▸ MTNR1A P48039 1/20 0.32
▸ MTNR1B P49286 1/20 0.32
▸ PAX8 Q06710 1/20 0.32
▸ CHRNB4 P30926 1/20 0.31
▸ CHRNA3 P32297 1/20 0.31
▸ PARP3 Q9Y6F1 1/20 0.31
▸ KDM4E B2RXH2 1/20 0.31
▸ MAPT P10636 1/20 0.31
▸ HPGD P15428 1/20 0.31
▸ EPHX2 P34913 1/20 0.31
▸ PRMT5 O14744 1/20 0.30
▸ WDR77 Q9BQA1 1/20 0.30
▸ TSHR P16473 1/20 0.30
▸ SMN1; SMN2 Q16637 1/20 0.30
▸ MEN1 O00255 1/20 0.30
▸ GAA P10253 1/20 0.30
▸ KMT2A Q03164 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL27712072 0.98 KCNH2 (0.33) KCNH2ALDH1A1CCKBRMTNR1AMTNR1B
Methylamine SCHEMBL28799881 0.95 MTNR1A (0.33) KCNH2ALDH1A1CCKBRMTNR1AMTNR1B
SCHEMBL21494400 0.82 F12 (0.36) —
SCHEMBL29557640 0.81 HPGD (0.33) KCNH2ALDH1A1CCKBRMTNR1AMTNR1B
SCHEMBL22864722 0.81 HPGD (0.33) KCNH2ALDH1A1CCKBRMTNR1AMTNR1B
SCHEMBL3139041 0.81 CA1 (0.33) KCNH2ALDH1A1CCKBRCHRNB4CHRNA3
Hydrochloric Acid SCHEMBL27907053 0.80 CA1 (0.33) KCNH2ALDH1A1CCKBRCHRNB4CHRNA3
SCHEMBL27582656 0.74 CHRNB4 (0.37) KCNH2ALDH1A1CCKBRMTNR1AMTNR1B
SCHEMBL28483533 0.74 EGFR (0.31) KCNH2
Ammonia Solution, Strong SCHEMBL7822449 0.72 F2 (0.35) ALDH1A1KDM4EMAPTHPGDSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103492376-B Bicyclic heterocycle compounds and their uses in therapy ASTEX THERAPEUTICS LTD 2015-07-22 — — CN disclosed
CN-103492376-A Bicyclic heterocycle compounds and their uses in therapy ASTEX THERAPEUTICS LTD 2014-01-01 — — CN disclosed
CN-102791131-A Compounds and methods GLAXOSMITHKLINE LLC 2012-11-21 — — CN disclosed
CN-100422214-C Emitter-binding peptides that produce a change in the spectral emission properties of the emitter MORPHOSYS AG (DE) 2008-10-01 — — CN disclosed
CN-1820027-A Emitter-binding peptides that produce a change in the spectral emission properties of the emitter MORPHOSYS AG (DE) 2006-08-16 — — CN disclosed
CN-1541098-A Combination therapy for treatment of cancer �ո��� 2004-10-27 — — CN disclosed
EP-1255752-A2 PYRROLE SUBSTITUTED 2-INDOLINONE PROTEIN KINASE INHIBITORS Sugen, Inc. (US) 2002-11-13 — — EP disclosed
WO-2001060814-A2 PYRROLE SUBSTITUTED 2-INDOLINONE PROTEIN KINASE INHIBITORS SUGEN, INC. (US) 2001-08-23 — — WO disclosed
Send feedback